U.S. Paper and Forestry Products Stock News

In recent days, The Times’ publication of extracts that prompted a high-profile response from the Duke and Duchess of Sussex concentrated reader attention on royal coverage, while Google faced renewed calls from European publishers including News Corp for EU regulators to conclude a long-running antitrust probe and impose penalties. Together, this surge in engagement around royal news and News Corp’s prominent role in pushing EU scrutiny of Google underscores how its UK media reach and...

Earlier in March 2026, Illumina announced a collaboration with Veritas Genetics Powered By Fuze Health to integrate whole-genome sequencing into preventive healthcare via insurance plans, while also advancing a large-scale multiomic drug discovery effort through its expanded Alliance for Genomic Discovery with Nashville Biosciences and new pharma partners. Together, these initiatives aim to make clinical-grade genomics and proteomics part of routine care and research, creating a large,...

Forgent Power Solutions (FPS) is back in focus after its fiscal second quarter and updated 2026 guidance, as strong revenue, bookings and backlog figures drew fresh attention from both the market and analysts. See our latest analysis for Forgent Power Solutions. The latest Q2 earnings release and 2026 revenue guidance helped push Forgent Power Solutions’ 1 day share price return to 11.6%, contributing to a 19.2% year to date share price return and signaling strengthening momentum. If you are...

NXP Semiconductors (NasdaqGS:NXPI) has drawn fresh attention after its board approved a US$1.014 interim dividend per share, paired with quarterly revenue growth above analyst estimates and an amended US$3b revolving credit agreement. See our latest analysis for NXP Semiconductors. Despite the fresh dividend announcement and new product updates in AI enabled processors, NXP Semiconductors' 30 day share price return of 21.49% decline and year to date share price return of 13.28% decline...

Cogent Biosciences (COGT) is in focus after the FDA accepted its New Drug Application for bezuclastinib in Non-Advanced Systemic Mastocytosis and set a PDUFA target action date of December 30, 2026. See our latest analysis for Cogent Biosciences. The FDA’s acceptance of the bezuclastinib NDA comes after a mixed stretch for the share price, with a 1-day share price return of 4.94% but a 90-day share price return decline of 10.78%. The 1-year total shareholder return is very large, indicating...

Why Ensign Group is on investors’ radar today Ensign Group (ENSG) has drawn attention after recent share price moves, with the stock showing mixed short term performance alongside stronger gains over the past 3 months and year. See our latest analysis for Ensign Group. At the current share price of $209.46, Ensign Group’s recent 1 day and 1 month share price returns have softened slightly. However, the 90 day share price return of 19.45% and 1 year total shareholder return of 61.61% suggest...

Intercontinental Exchange (ICE) has been in focus after a new relationship and investment in OKX, plans for container freight futures, fresh mortgage tech integrations, and fresh data on US$205b of homeowner equity withdrawals. See our latest analysis for Intercontinental Exchange. ICE’s recent OKX investment, planned container freight futures and mortgage technology integrations come as the share price trades at US$161.49, with a 30 day share price return of 6.05% but a 1 year total...

Cboe Global Markets (CBOE) has put fresh attention on its stock with two new product moves: a planned bitcoin volatility index and a new prediction market framework that reshapes outcome-based trading payouts. See our latest analysis for Cboe Global Markets. The latest product announcements come as momentum in the stock has been building, with a 90-day share price return of 15.67% and a 1-year total shareholder return of 34.32%, while multi year total returns remain strong overall. If news...

Pampers, Procter & Gamble’s flagship baby-care brand, recently launched Pampers AMORE in the US, its most premium and most absorbent diaper line since Pampers Pure in 2018, featuring five-layer protection, clinically proven hypoallergenic materials, and transparent ingredient claims for newborns through toddlers. This launch underscores Procter & Gamble’s push further into the high-end diaper segment, where advanced performance and safety credentials can help deepen brand loyalty among...

Navigator Holdings Ltd. reported its fourth-quarter and full-year 2025 results, with Q4 revenue rising to US$152.83 million while quarterly net income eased to US$18.48 million, and full-year net income increased to US$100.12 million on revenue of US$586.96 million. Alongside record annual profitability, the company raised its fixed dividend and expanded its capital return policy, signaling confidence in its balance sheet and in the earnings power of its liquefied gas fleet and export...

Astronics wins Boeing 737 MAX fuel tank access door contract Astronics (ATRO) drew fresh attention after Boeing selected the company to supply fuel tank access doors for the 737 MAX program, further linking its Clackamas, Oregon facility to a key commercial platform. See our latest analysis for Astronics. The Boeing contract lands as Astronics trades at US$68.70, with a 1 day share price return of 7.46%, following a 30 day share price return decline of 10.71%, and a 1 year total shareholder...

Solaris Energy Infrastructure recently closed two deals that will add about 900 MW of new natural gas-fueled turbine capacity by 2029, including the acquisition of Genco Power Solutions and the purchase of 30 turbine delivery slots, funded through a mix of cash, new shares, assumed debt, and a new US$300 million credit facility. This expansion program will lift Solaris’s total operated power generation capacity to roughly 3,100 MW by 2029 and commits the company to approximately US$935...

W. R. Berkley (WRB) is back in focus after a softer Q4, with revenue and book value per share missing forecasts while earnings per share matched estimates, yet the share price has firmed. See our latest analysis for W. R. Berkley. At a share price of US$68.53, W. R. Berkley has given investors a modest year to date share price decline alongside a 1 year total shareholder return of 9.8%, while the 5 year total shareholder return of 137.02% points to strong compounding over time. The recent...

Spyre Therapeutics recently reported that it has completed recruitment for the rheumatoid arthritis (RA) sub-study of its SKYWAY Phase 2 basket trial evaluating SPY072, an extended half-life TL1A-targeting antibody, and has accelerated the expected timing of topline proof-of-concept data to the third quarter of 2026 for RA and the fourth quarter of 2026 for psoriatic arthritis and axial spondyloarthritis. This progress underscores how basket and platform trial designs could speed clinical...

Installed Building Products (IBP) has drawn fresh investor attention after reporting earnings supported by its heavy commercial segment, even as single-family housing and private non-residential development remain areas of uncertainty for the business. See our latest analysis for Installed Building Products. The current share price of $288.33 comes after a 16.23% 1 month share price decline and a 3.66% 7 day pullback, even though the 1 year total shareholder return of 70.83% and 3 year total...

Analyst actions and operational momentum APA (APA) has moved into focus after several banks adjusted their views, pairing rating affirmations with higher price targets as management reported earlier than expected cost cuts and steady operational updates. See our latest analysis for APA. Those earlier cost cuts and consistent production updates have coincided with a sharp shift in sentiment, with a 30 day share price return of 23.71% and a 1 year total shareholder return of 81.35% suggesting...

Conference spotlight and mixed corporate signals for Service Corporation International Service Corporation International (SCI) is in focus after a mixed set of developments, including a quarterly earnings miss on both adjusted EPS and revenue, a new cash dividend, and insider share sales. See our latest analysis for Service Corporation International. Recent events around the earnings miss, new dividend, and insider sale appear to have checked enthusiasm, with the share price roughly flat over...

Recent performance and business profile Figure Technology Solutions (FIGR) has drawn attention after a mixed period for the stock, with a slight gain over the past month contrasting with a negative move over the past 3 months and year to date. The Reno based financial technology company focuses on blockchain based products for lending, trading and investing in the United States. The company reported revenue of US$432.055m and net income of US$133.858m in its latest figures. See our latest...

Scorpio Tankers Inc. recently announced it agreed to sell three 2015-built scrubber-fitted product tankers for a total of US$130.0 million and to time charter-out two LR2 tankers on multi-year contracts starting in 2026, while the Strait of Hormuz closure has disrupted vessel traffic and pushed product tanker rates higher. This combination of asset sales, fresh long-term contract coverage, and geopolitically driven rate strength reshapes how stable and visible Scorpio Tankers’ future cash...

What Fidelis Insurance Holdings’ completed buyback means for shareholders Fidelis Insurance Holdings (FIHL) has just wrapped up a sizeable buyback, repurchasing 18,823,327 shares for US$351.4 million, equal to 18.24% of its share base under a program launched in August 2025. From October 1, 2025 to March 3, 2026 alone, the company bought back 16,988,264 shares, or 16.49% of its stock, at a time when the shares most recently closed at US$18.95. See our latest analysis for Fidelis Insurance...

Pharvaris recently reported that a company-sponsored real-world, mixed methods study on patient experiences during acute hereditary angioedema (HAE) attacks and related clinical endpoints has been published in Clinical Reviews in Allergy & Immunology, supporting the use of several patient-reported outcome (PRO) tools in ongoing and future deucrictibant trials. The study’s finding that patients view even small early improvements, captured by the End of Progression™ endpoint, as meaningfully...

In recent weeks, Sesame Workshop filed a lawsuit against United Parks & Resorts, alleging unpaid royalties and contract breaches tied to Sesame Street–branded attractions, while SeaWorld Orlando continued building its new SeaQuest: Legends of the Deep ride amid heightened geopolitical and oil market uncertainty. At the same time, institutional investor Melqart Asset Management disclosed a new stake in the company, highlighting how legal risks, new attraction investments, and shifting...

Atlas Air placed its first major Airbus order for 20 A350 freighters, moving away from Boeing freighters because of delays on the 777-8 cargo program. Boeing (NYSE:BA) is asking suppliers to disclose any operational impacts from supply chain disruptions linked to the U.S. conflict with Iran and tensions involving Israel. These developments raise questions about Boeing's future position in the air cargo market and its ability to sustain production schedules across commercial programs. For...

In early March 2026, Zoom and partners including Pindrop, PCI Pal, and eGain announced integrations bringing deepfake detection, secure in-interaction payments, and AI-guided knowledge into Zoom’s Workplace, Phone, and CX platforms, alongside Zoom’s own expanded agentic AI workflow and automation capabilities. These moves push Zoom further into being an AI-powered workflow and customer engagement hub, embedding security, compliance, and automation directly into everyday collaboration rather...